Skip to main content

Table 1 Patient characteristics, clinical measures and association with HbA1c

From: Characteristics of poorly controlled Type 2 diabetes patients in Swiss primary care

 

Mean ± SD or n (%)

Association with HbA1c1)

Coefficient

P-value

Anthropometrics and sociodemographics

Age (years)

67.1 ± 10.6

-0.167

0.003 a)

Male gender (n, %)

187 (57.4)

 

0.675 b)

Nationality Swiss (n, %)

291 (91.8)

 

0.228 b)

Living together with partner/family (n, %)

246 (78.3)

 

0.392 b)

Still working (n, %)

100 (32.2)

 

0.249 b)

Education (years)

11.6 ± 3.2

-0.027

0.632 a)

Smoking status

  

0.780 c)

Current smoker (n, %)

36 (11.5)

  

Former smoker (n, %)

129 (41.1)

  

Never smoker (n, %)

149 (47.4)

  

Diabetes variables

Duration of diabetes (years)

9.9 ± 7.6

0.019

0.740 a)

Family history of Type 2 diabetes (n, %)

186 (57.6)

 

0.987 b)

Glycated haemoglobin (HbA1c, %)

7.7 ± 1.3

  

Fasting serum glucose (mmol/l)

8.0 ± 2.4

0.472

0.000 a)

Severe hypoglycaemia (≥1, %) 2)

32 (9.8)

 

0.937 b)

Hyperglycaemic episodes (≥1, %) 2)

19 (5.8)

 

0.091 b), 4d)

Self monitoring of blood glucose

none (n, %)

65 (19.9)

 

0.352 b)

daily (≥1) (n, %)

133 (40.8)

 

0.122 b)

weekly (≥1) (n, %)

101 (31.0)

 

0.205 b)

monthly (≥1) (n, %)

27 (8.3)

 

0.707 b)

Foot status (pathological; n, %)

52 (16)

 

0.105 b)

Peripheral pulse status (pathological; n, %)

97 (29.8)

 

0.387 b)

Monofilament test (pathological; n, %)

42 (13.5)

 

0.091 b), 4e)

Vibratory sensation (pathological; n, %)

81 (24.9)

 

0.735 b)

Annual dilated eye exam

pathological (n, %)

28 (8.7)

 

0.898 b)

non-pathological (n, %)

194 (60.1)

 

0.376 b)

not conducted (n, %)

101 (31.2)

 

0.372 b)

Clinical and laboratory measures

Number of consultations last year

8.07 ± 6.0

-0.051

0.355 a)

Compliance (1 = very good, 4 = very bad)

1.87 ± 0.7

0.161

0.004 a)

   

0.027 c),3),4f)

very good

109 (33.6)

  

rather good

149 (46)

  

rather bad

64 (19.8)

  

very bad

2 (0.6)

  

Blood pressure systolic (mmHg)

139.1 ± 17.6

-0.004

0.941 a)

Blood pressure diastolic (mmHg)

80.9 ± 10.5

0.101

0.070 a)

Pulse

73.7 ± 11.9

0.024

0.671 a)

Body-mass index (BMI; kg/m2)

30.6 ± 5.6

0.137

0.013 a)

Waist circumference (cm)

108.3 ± 12.4

0.105

0.059 a)

Waist-hip ratio (cm/cm)

1.0 ± 0.1

0.006

0.910 a)

Cholesterol (mmol/l)

   

Total

4.8 ± 1.1

0.069

0.214 a)

Low-density lipoprotein (LDL)

2.7 ± 1.1

0.072

0.196 a)

High-density lipoprotein (HDL)

1.2 ± 0.4

-0.088

0.113 a)

Creatinine (μmol/l)

82.1 ± 26.8

-0.009

0.866 a)

Creatinine-Clearance according to Cockcroft

96.3 ± 47.6

0.108

0.052 a)

  1. 1) a) Associations HbA1c with continuous variables by Pearson correlations (coefficient), between HbA1c and categorical variables by b) t-tests and c) ANOVA.
  2. 2) In the last 12 months.
  3. 3) Compliance categories “rather bad & very bad” categorised because of “very bad” n = 2.
  4. 4) HbA1c (%) mean per category of significant t-test and ANOVA results (p < 0.010): d) Hyperglycaemic episodes: yes = 8.5, no = 7.6; e) Monofilament test: pathological = 7.5, non-pathological = 7.8; f) Compliance: very good = 7.5, rather good = 7.7, rather bad & very bad = 8.0.